Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III

Fibroblast Activation Protein (FAP)-Mediated Cleavage of Type III Collagen Reveals Serum Biomarker Potential in Non-Small Cell Lung Cancer and Spondyloarthritis (2024) Pedersen RS, Thorlacius-Ussing J, Raimondo MG, Langholm LL, Schett G, Ramming A, Karsdal M, Willumsen N Journal article Patient Experiences and Challenges in the Management of Autoinflammatory Diseases—Data from the International FMF & AID Global Association Survey (2024) Rech J, Schett G, Tufan A, Kuemmerle-Deschner JB, Özen S, Tascilar K, Geck L, et al. Journal article Exploring Epipolar Consistency Conditions for Rigid Motion Compensation in In-vivo X-ray Microscopy (2024) Thies M, Wagner F, Gu M, Mei S, Huang Y, Pechmann S, Aust O, et al. Conference contribution, Conference Contribution Metabolic and molecular imaging in inflammatory arthritis (2024) Noversa de Sousa R, Tascilar K, Corte G, Atzinger A, Minopoulou I, Ohrndorf S, Waldner M, et al. Journal article, Review article CCL19‐positive lymph node stromal cells govern the onset of inflammatory arthritis via tropomyosin receptor kinase (2024) Schälter F, Azizov V, Frech M, Dürholz K, Schmid E, Hendel A, Sarfati I, et al. Journal article Enhancing student understanding of rheumatic disease pathologies through augmented reality: findings from a multicentre trial. (2024) Pfeil A, Klemm P, Hueber AJ, Hoffmann T, Weise T, Oelzner P, Knop S, et al. Journal article CAR-T-Zell-Therapie in der Rheumatologie – Was wissen wir bisher? (2024) Hagen M, Wirsching A, Bohr D, Taubmann J, Müller F, Mackensen A, Grieshaber Bouyer R, Schett G Journal article Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis (2024) Siebert S, Coates LC, Schett G, Raychaudhuri SP, Chen W, Gao S, Seridi L, et al. Journal article Comparison and Improvement of CyberGlove III calibration methods (2024) Heinrich S, Michaelis J, Reiher I, Coppers B, Lohmayer M, Fleischmann ME, Kleyer A, et al. Journal article, Original article Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study. (2024) Minopoulou I, Tascilar K, Corte G, Mutlu MY, Schmidt K, Bohr D, Hartmann F, et al. Journal article